secwatch.observer — SEC 8-K summary
======================================

Issuer:     LivaNova PLC (LIVN)
CIK:        0001639691
Form:       8-K
Filed at:   2025-09-04T23:59:59+00:00
Accession:  0001639691-25-000120
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

LivaNova appoints Donald Zurbay to Board and Audit Committee
------------------------------------------------------------

- Donald Zurbay appointed to LivaNova Board and Audit & Compliance Committee effective September 4, 2025.
- Zurbay most recently President & CEO of Patterson Companies (Oct 2022-May 2025); previously CFO at Patterson and St. Jude Medical.
- Compensation: $70k annual retainer, $15k audit committee fee, $185k annual restricted stock award, prorated until 2026 AGM.
- No material transactions or arrangements between Zurbay and LivaNova per Item 404(a) review.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1639691/000163969125000120/0001639691-25-000120-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1639691/000163969125000120/livn-20250903.htm
  HTML page:      https://secwatch.observer/filing/0001639691-25-000120

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer